Back

Effects of sacubitril/valsartan on atrial function and structure as treatment response indicators in patients with heart failure with reduced ejection fraction: an observational prospective study.

21 May 2023 (15:00 - 15:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - imaging 1 Imaging HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Massimiliano Camilli

Catholic University of the Sacred Heart, Rome (Italy)

6 More presentations in this session

Presentation thumbnail
Integrated catecholamine imaging in heart and lung across different cardiopulmonary disorders: a systems-based pilot analysis
Doctor C. Borrelli (Pisa, IT)
Abstract Slides
Presentation thumbnail
The effect of transmitral to tissue Doppler imaging early diastolic velocity ratio on the prognosis according to the beta-blocker use in patients with acute heart failure
Professor S. Kim (Ulsan, KR)
Abstract Slides
Presentation thumbnail
Myocardial work for LV function assessment in severe AS patients undergoing TAVR
Miss A. Moya (Aalst, BE)
Abstract Slides
Presentation thumbnail
In patients with unexplained dyspnea and preserved left ventricular ejection fraction CPETecho is a useful tool to establish the cause of dyspnea
Doctor L. Meems (Groningen, NL)
Abstract Slides
Presentation thumbnail
A machine learning derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: the HOMAGE trial
Doctor M. Kobayashi (Tokyo, JP)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - imaging 1

The Event

Event poster

Heart Failure 2023

21 May 2023 15:00 CET
You may be interested in
thumbnail
Congress Session
Recent advances in clinical practice guidelines: what the imager needs to know and apply - Part 2
thumbnail
Congress Presentation
Heart failure
thumbnail
Congress Session
Imaging evaluation of heart failure with preserved ejection fraction: all you need to know!

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources